RxDoctor Payments Data

Rasheed Abiola, MD

Orthopaedic Surgery of the Spine · Livonia, MINPI 1659669075

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Alphatec Spine, Inc at 56.8% of the total. 2025 is the largest year on record at $21,335, more than ten times the $1,975 reported in 2019.

$43,492in general payments, 2019–2025

Across 205 payments — averaging $212.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$25K
  • Medtronic$6K
  • Globus Medical$3K
  • Si-bone, Inc.$2K
  • Spineart USA Inc$2K
  • Stryker$2K
  • plus $4K from 20 others

What the payments were for

  • Consulting fees$10,03823%
  • Travel & lodging$23,17853%
  • Food & beverage$10,27724%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,492 in reported general payments places this provider in the 70th percentile of 37 orthopaedic surgery of the spine providers in Michigan.

See all orthopaedic surgery of the spine providers in Michigan

Medicare billing

Part B allowed, 2024
$292,710
Medicare patients
351
Services billed
1,825

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin268$1,827
Methylprednisolone234$1,408
Meloxicam172$1,206
Celecoxib48$1,182

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Livonia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →